Anti-MAVS monoclonal antibody

Pre-made anti-MAVS monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MAVS/MAVS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1153-Ab-1/ GM-Tg-hg-IP1153-Ab-2Anti-Human MAVS monoclonal antibodyHuman
GM-Tg-rg-IP1153-Ab-1/ GM-Tg-rg-IP1153-Ab-2Anti-Rat MAVS monoclonal antibodyRat
GM-Tg-mg-IP1153-Ab-1/ GM-Tg-mg-IP1153-Ab-2Anti-Mouse MAVS monoclonal antibodyMouse
GM-Tg-cynog-IP1153-Ab-1/ GM-Tg-cynog-IP1153-Ab-2Anti-Cynomolgus/ Rhesus macaque MAVS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1153-Ab-1/ GM-Tg-felg-IP1153-Ab-2Anti-Feline MAVS monoclonal antibodyFeline
GM-Tg-cang-IP1153-Ab-1/ GM-Tg-cang-IP1153-Ab-2Anti-Canine MAVS monoclonal antibodyCanine
GM-Tg-bovg-IP1153-Ab-1/ GM-Tg-bovg-IP1153-Ab-2Anti-Bovine MAVS monoclonal antibodyBovine
GM-Tg-equg-IP1153-Ab-1/ GM-Tg-equg-IP1153-Ab-2Anti-Equine MAVS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1153-Ab-1/ GM-Tg-hg-IP1153-Ab-2; GM-Tg-rg-IP1153-Ab-1/ GM-Tg-rg-IP1153-Ab-2;
GM-Tg-mg-IP1153-Ab-1/ GM-Tg-mg-IP1153-Ab-2; GM-Tg-cynog-IP1153-Ab-1/ GM-Tg-cynog-IP1153-Ab-2;
GM-Tg-felg-IP1153-Ab-1/ GM-Tg-felg-IP1153-Ab-2; GM-Tg-cang-IP1153-Ab-1/ GM-Tg-cang-IP1153-Ab-2;
GM-Tg-bovg-IP1153-Ab-1/ GM-Tg-bovg-IP1153-Ab-2; GM-Tg-equg-IP1153-Ab-1/ GM-Tg-equg-IP1153-Ab-2
Products NameAnti-MAVS monoclonal antibody
Formatmab
Target NameMAVS
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MAVS monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1153-Ag-1Recombinant multi-species MAVS/ CARDIF/ IPS-1 protein
    ORF Viral VectorpGMLP001134human MAVS Lentivirus plasmid
    ORF Viral VectorvGMLP001134human MAVS Lentivirus particle
    ORF Viral VectorpGMLPm002706mouse Mavs Lentivirus plasmid
    ORF Viral VectorvGMLPm002706mouse Mavs Lentivirus particle


    Target information

    Target IDGM-IP1153
    Target NameMAVS
    Gene ID57506,228607,311430,717616,485789,101085709,618508,100066212
    Gene Symbol and SynonymsCARDIF,D430028G21Rik,IPS-1,IPS1,MAVS,VISA
    Uniprot AccessionQ7Z434,Q66HG9
    Uniprot Entry NameMAVS_HUMAN,MAVS_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000088888
    Target ClassificationN/A

    The target: MAVS, gene name: MAVS, also named as CARDIF, IPS-1, IPS1, VISA. This gene encodes an intermediary protein necessary in the virus-triggered beta interferon signaling pathways. It is required for activation of transcription factors which regulate expression of beta interferon and contributes to antiviral innate immunity. [provided by RefSeq, Jul 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.